Company Overview and News

 
Stock With Momentum: Gas Malaysia

2018-09-05 theedgemarkets
Gas Malaysia Bhd (-ve) Trading in shares of Gas Malaysia Bhd (fundamental: 2.1/3, valuation: 1.7/3) triggered our momentum algorithm yesterday for the third time this year.
5209

 
ARREIT, Gas Malaysia, Pesona and Minho

2018-09-04 theedgemarkets
KUALA LUMPUR (Sept 4): theedgemarkets.com highlighted four stocks with momentum at Bursa Malaysia’s afternoon market close today. Three stocks displayed negative momentum while one showed positive momentum.
5209 BSMAF 1818

 
Trading ideas: FGV, Marine & General, Vertice, Vizione, DBE Gurney, AirAsia

2018-09-04 thestar.com.my
KUALA LUMPUR: FGV Holdings Bhd, Marine & General Bhd, Vertice Bhd, Vizione Holdings Bhd , DBE Gurney Resources Bhd and AirAsia Group Bhd are among the stocks to watch, according to JF Apex Research.
5209

 
Lotte Chemical, AirAsia, FGV, Marine & General, HeveaBoard, Uzma, Vertice, Vizione, DBE Gurney and Supermax

2018-09-03 theedgemarkets
KUALA LUMPUR (Sept 3): Based on corporate announcements and news flow today, companies that may be in focus tomorrow (Sept 4) may include the following: Lotte Chemical Titan Holding Bhd, AirAsia Group Bhd, FGV Holdings Bhd, Marine & General Bhd, HeveaBoard Bhd, Uzma Bhd, Vertice Bhd, Vizione Holdings Bhd, DBE Gurney Resources Bhd.and Supermax Corp Bhd.
FLY SPMXY 5209 SPMXF BSMAF 1818

 
Marine & General gets one-year extension on vessels contract

2018-09-03 theedgemarkets
KUALA LUMPUR (Sept 3): Marine & General Bhd (M&G) has received a one-year extension on its contract from Repsol Oil & Gas Malaysia Ltd for the provision of two anchor handling tug supply vessels.
5209

 
MMC Corp's 2Q profit slumps on lower contributions from ports, Malakoff

2018-08-24 theedgemarkets
KUALA LUMPUR (Aug 24): MMC Corp Bhd's net profit slumped 66% to RM20.08 million in the second quarter ended June 30, 2018 (2QFY18), from RM59.81 million a year ago, due largely to lower contribution from Johor Port Bhd and Northport (Malaysia) Bhd.
5209

 
Utusan, Petrol One, Eita Resources, Gadang, Dayang Enterprise, PetDag, Allianz, United Plantations, E&O, Velesto Energy, Amway and Rex Industry

2018-08-20 theedgemarkets
KUALA LUMPUR (Aug 20): Based on corporate announcements and news flow today, companies in focus on Tuesday (Aug 21) may include the following: Utusan Melayu (Malaysia) Bhd, Petrol One Resources Bhd, Eita Resources Bhd, Gadang Holdings Bhd, Dayang Enterprise Holdings Bhd, Petronas Dagangan Bhd, Allianz Malaysia Bhd, United Plantations Bhd, Eastern and Oriental Bhd (E&O), Velesto Energy Bhd, Amway (Malaysia) Holdings Bhd and Rex Industry Bhd.
9261 UPBMF 5681 5141 7027 1163 2089 5754 5209 5208 9946 BSMAF 1818

 
Dayang Enterprise bags 2 five-year jobs; value based on work orders

2018-08-20 theedgemarkets
KUALA LUMPUR (Aug 20): Dayang Enterprise Holdings Bhd has secured two five-year maintenance, construction and modification contracts via its wholly-owned subsidiary Dayang Enterprise Sdn Bhd (DESB).
5209 5141

 
Gas Malaysia FY18 sales seen to expand

2018-08-10 theedgemarkets
Gas Malaysia Bhd (Aug 9, RM2.90) Maintain buy with an unchanged target price (TP) of RM3.50: Gas Malaysia Bhd’s reported earnings in the second quarter ended June 30, 2018 (2QFY18) surged 42.4% year-on-year (y-o-y) to RM48.1 million. The company’s six months of FY18 earnings came in broadly within our and consensus expectations, making up 45% and 48% of FY18 earnings estimates, respectively. We continue to expect stronger quarters ahead as the second half is typically a stronger period for Gas Malaysia.
5209

 
Gas Malaysia up 2.73% after 42% jump in 2Q earnings

2018-08-09 theedgemarkets
KUALA LUMPUR (Aug 9): Gas Malaysia Bhd rose 2.73% in early trade this morning after it reported a 42% jump in its net profit for the second quarter ended June 30, 2018 (2QFY18) to RM48.07 million from RM33.76 million in the year-ago quarter, thanks to a higher volume of natural gas sold and higher natural gas tariff.
5209

 
Gas Malaysia shares rise in early trade after profit surge

2018-08-09 thestar.com.my
KUALA LUMPUR: Shares in Gas Malaysia Bhd rose in early trade Thursday after its second-quarter net profit jumped 42% year-on-year.
5209

 
Trading ideas: Gas Malaysia, Kelington, Zecon, IJM Corp, ECS ICT

2018-08-09 thestar.com.my
KUALA LUMPUR: Gas Malaysia Bhd , Kelington Group Bhd , Zecon Bhd , IJM Corp Bhd and ECS ICT Bhd are among the stocks to watch on Thursday, according to JF Apex Research.
5209 5162 0151

 
KLCI gets off on a flat note, tracks subdued region

2018-08-09 theedgemarkets
KUALA LUMPUR (Aug 9): The FBM KLCI started on a flast note this morning, tracking its subdued regional peers.
PBLOF 5183 PECGF 1295 DKSHY 2852 5347 3301 3867 5209 TNABY TNABF 5908 DKSHF

 
KLCI seen trending sideways, immediate hurdle at 1,809

2018-08-08 theedgemarkets
KUALA LUMPUR (Aug 9): The FBM KLCI is seen trending sideways today with immediate hurdle at 1,809 in line with the global markets where trade jitters kept sentiment in check.
DKSHY 5209 5162 0151 5123 DKSHF 5908

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...